Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLiabilities from Discontinued OperationsLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Cresco Labs (CRLBF) Accumulated Expenses (2022 - 2026)

Cresco Labs filings provide 5 years of Accumulated Expenses readings, the most recent being $55.0 million for Q1 2026.

  • On a quarterly basis, Accumulated Expenses fell 1.98% to $55.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $55.0 million, a 1.98% decrease, with the full-year FY2025 number at $58.0 million, up 6.85% from a year prior.
  • Accumulated Expenses hit $55.0 million in Q1 2026 for Cresco Labs, down from $58.0 million in the prior quarter.
  • In the past five years, Accumulated Expenses ranged from a high of $96.0 million in Q1 2022 to a low of $45.9 million in Q2 2022.
  • Median Accumulated Expenses over the past 5 years was $56.1 million (2025), compared with a mean of $59.6 million.
  • Biggest five-year swings in Accumulated Expenses: decreased 21.4% in 2024 and later increased 6.85% in 2025.
  • Cresco Labs' Accumulated Expenses stood at $58.6 million in 2022, then grew by 17.9% to $69.1 million in 2023, then fell by 21.4% to $54.3 million in 2024, then increased by 6.85% to $58.0 million in 2025, then decreased by 5.14% to $55.0 million in 2026.
  • The last three reported values for Accumulated Expenses were $55.0 million (Q1 2026), $58.0 million (Q4 2025), and $50.1 million (Q3 2025) per Business Quant data.